Hyaluronan signaling to nociceptors in inflammatory pain
炎症性疼痛中透明质酸向伤害感受器发出信号
基本信息
- 批准号:10339337
- 负责人:
- 金额:$ 61.73万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-04-05 至 2024-01-31
- 项目状态:已结题
- 来源:
- 关键词:Absence of pain sensationAcute PainAffectAfferent NeuronsAnalgesicsApplications GrantsArthritisAttenuatedBindingBradykininCD44 AntigensCD44 geneCapsaicinCell membraneClinicalConnective Tissue DiseasesCutaneousDegenerative polyarthritisDermatitisDevelopmentDiseaseDoseElectrophysiology (science)ElementsExtracellular MatrixFiberFunctional disorderHyaluronanHyperalgesiaIn VitroInflammationInflammation MediatorsInflammatoryInjuryIntra-Articular InjectionsIon ChannelJointsLigandsMechanicsMediatingMethodsModalityMolecular WeightMovementNerveNerve EndingsNeuronsNeuropathyNociceptionNociceptorsPainPain ResearchPain managementPatientsPlayPopulationPre-Clinical ModelPropertyPublicationsReactive Oxygen SpeciesReportingResearchRoleSecond Messenger SystemsSignal PathwaySignal TransductionSpinal GangliaStressSupporting CellSyndromeSynovial jointTRPV1 geneTestingTherapeuticTissuesUrateattenuationbasechronic painclinical painexperimental studyimprovedin vivoinflammatory paininsightjoint inflammationknock-downmechanical forcenovelosteoarthritis painpain modelpain reductionpatch clamprational designreceptorsexual dimorphismtissue injuryviscoelasticityvoltage clamp
项目摘要
PROJECT SUMMARY/ABSTRACT
The extracellular matrix (ECM) plays a major role in the pathophysiology of painful connective tissue diseases
characterized by inflammation and tissue injury, such as arthritis and dermatitis. High molecular weight
hyaluronan (HMWH), the major non-protein component of the ECM, is metabolized to low molecular weight
hyaluronans (LMWH) in these clinical conditions. In preliminary studies we have shown that LMWH sensitizes
synovial and cutaneous nociceptors, and produces articular and cutaneous mechanical hyperalgesia. In contrast,
HMWH is currently used in the treatment of pain in patients with arthritis and other connective tissue diseases,
and while current dogma teaches that the analgesic properties of HMWH are due to its viscoelastic properties,
we propose the novel hypothesis that both HMWH-induced analgesia/anti-hyperalgesia, and LMWH-induced
mechanical hyperalgesia are both generated by their action at the cognate hyaluronan (HA) receptor, CD44, in
the plasma membrane of pain sensory neurons (nociceptors). To test this hypothesis, we will: 1)
comprehensively study the pro- and anti-nociceptive properties of these two size classes of HA to establish the
properties of LMWH that induce pain (hyperalgesia) and HMWH that induce analgesia (anti-hyperalgesia); 2)
use in vitro patch-clamp electrophysiology to establish that HA acts directly on nociceptors to sensitize (LMWH)
or reverse sensitization (HMWH) of nociceptor excitability, and determine the nociceptor populations upon which
HAs act to produce their effects and the ion channels in each population whose function is modulated by HA; 3)
confirm the role of the cognate hyaluronan receptor, CD44 and its downstream second messenger signaling
pathways, in LMWH hyperalgesia and HMWH analgesia, and that the CD44 is in nociceptors; and, 4) use
preclinical models of inflammatory, neuropathic and stress-induced pain to demonstrate that nociceptor CD44 is
involved in the pain in with these syndromes, and that HMWH can be used as an anti-hyperalgesia/analgesia
therapeutic modality. The proposed experiments will provide insight into the role of an important element of the
ECM in diverse pain syndromes, and a rationale for developing new, more effective forms of HMWH to treat
pain.
项目摘要/摘要
细胞外基质(ECM)在痛性结缔组织病的病理生理学中起重要作用。
以炎症和组织损伤为特征的,如关节炎和皮炎。高分子量
透明质酸(HMWH)是细胞外基质的主要非蛋白质成分,被代谢成低分子量
透明质酸(LMWH)在这些临床条件下。在初步研究中,我们已经表明低分子肝素能敏化
滑膜和皮肤伤害性感受器,并产生关节和皮肤机械性痛觉过敏。相比之下,
HMWH目前用于治疗关节炎和其他结缔组织疾病患者的疼痛,
虽然目前的教条教导说,HMWH的止痛特性是由于其粘弹性特性,
我们提出了一个新的假设,即高分子肝素诱导的镇痛/抗痛觉过敏和低分子肝素诱导的
机械性痛敏都是由它们在同源透明质酸(HA)受体CD44上的作用而产生的。
痛觉神经元(伤害性感受器)的质膜。为了检验这一假设,我们将:1)
综合研究这两种粒径HA的促痛和抗伤害性,以建立
低分子肝素引起疼痛(痛敏)和高分子肝素诱导止痛(抗痛觉过敏)的特性;2)
利用体外膜片钳电生理学证实HA直接作用于伤害性感受器敏化(LMWH)
或伤害性感受器兴奋性的反向敏化(HMWH),并确定其上的伤害性感受器种群
有作用产生它们的作用和每个群体中的离子通道,其功能受HA调节;3)
确认同源透明质酸受体CD44及其下游第二信使信号的作用
低分子肝素痛敏和高分子肝素镇痛中的通路,以及CD44在伤害性感受器中的作用;以及,4)使用
炎症、神经病理性和应激性疼痛的临床前模型证明伤害性感受器CD44是
与这些症状有关的疼痛,HMWH可用作抗痛觉过敏/止痛
治疗方式。拟议的实验将使我们深入了解
不同疼痛综合征中的ECM,以及开发新的、更有效的HMWH治疗形式的理论基础
疼痛。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JON DAVID LEVINE其他文献
JON DAVID LEVINE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JON DAVID LEVINE', 18)}}的其他基金
Hyaluronan signaling to nociceptors in inflammatory pain
炎症性疼痛中透明质酸向伤害感受器发出信号
- 批准号:
10558628 - 财政年份:2019
- 资助金额:
$ 61.73万 - 项目类别:
Chronic Chemotherapy Peripheral Neuropathy: Role of Neuroplasticity and Stress
慢性化疗周围神经病变:神经可塑性和压力的作用
- 批准号:
10472499 - 财政年份:2019
- 资助金额:
$ 61.73万 - 项目类别:
Hyaluronan signaling to nociceptors in inflammatory pain
炎症性疼痛中透明质酸向伤害感受器发出信号
- 批准号:
10091973 - 财政年份:2019
- 资助金额:
$ 61.73万 - 项目类别:
Chronic Chemotherapy Peripheral Neuropathy: Role of Neuroplasticity and Stress
慢性化疗周围神经病变:神经可塑性和压力的作用
- 批准号:
10229396 - 财政年份:2019
- 资助金额:
$ 61.73万 - 项目类别:
Hyaluronan signaling to nociceptors in inflammatory pain
炎症性疼痛中透明质酸向伤害感受器发出信号
- 批准号:
9750359 - 财政年份:2019
- 资助金额:
$ 61.73万 - 项目类别:
Chronic Chemotherapy Peripheral Neuropathy: Role of Neuroplasticity and Stress
慢性化疗周围神经病变:神经可塑性和压力的作用
- 批准号:
10013159 - 财政年份:2019
- 资助金额:
$ 61.73万 - 项目类别:
Chronic Chemotherapy Peripheral Neuropathy: Role of Neuroplasticity and Stress
慢性化疗周围神经病变:神经可塑性和压力的作用
- 批准号:
10701692 - 财政年份:2019
- 资助金额:
$ 61.73万 - 项目类别:
Chronic Chemotherapy Peripheral Neuropathy: Role of Neuroplasticity and Stress
慢性化疗周围神经病变:神经可塑性和压力的作用
- 批准号:
9986945 - 财政年份:2019
- 资助金额:
$ 61.73万 - 项目类别:
Hyaluronan signaling to nociceptors in inflammatory pain
炎症性疼痛中透明质酸向伤害感受器发出信号
- 批准号:
9908043 - 财政年份:2019
- 资助金额:
$ 61.73万 - 项目类别:
Nociceptor mechanisms in the transition from acute to chronic pain
从急性疼痛转变为慢性疼痛的伤害感受器机制
- 批准号:
8976453 - 财政年份:2014
- 资助金额:
$ 61.73万 - 项目类别:
相似海外基金
Clinical Outcome Assessments for Acute Pain Therapeutics in Infants and young Children (COA APTIC)
婴幼儿急性疼痛治疗的临床结果评估 (COA APTIC)
- 批准号:
10778757 - 财政年份:2023
- 资助金额:
$ 61.73万 - 项目类别:
Selective actin remodeling of sensory neurons for acute pain management
感觉神经元的选择性肌动蛋白重塑用于急性疼痛管理
- 批准号:
10603436 - 财政年份:2023
- 资助金额:
$ 61.73万 - 项目类别:
Clinical Outcome Assessments for Acute Pain Therapeutics in Infants and young Children (COA APTIC)
婴幼儿急性疼痛治疗的临床结果评估 (COA APTIC)
- 批准号:
10783106 - 财政年份:2023
- 资助金额:
$ 61.73万 - 项目类别:
Development of A Focused Ultrasound Device for Noninvasive, Peripheral Nerve Blockade to Manage Acute Pain
开发用于非侵入性周围神经阻断来治疗急性疼痛的聚焦超声装置
- 批准号:
10740796 - 财政年份:2023
- 资助金额:
$ 61.73万 - 项目类别:
Predicting Pediatric Sickle Cell Disease Acute Pain Using Mathematical Models Based on mHealth Data
使用基于移动健康数据的数学模型预测儿童镰状细胞病急性疼痛
- 批准号:
10599401 - 财政年份:2022
- 资助金额:
$ 61.73万 - 项目类别:
Non-Contingent Acute Pain Stress Drives Analgesic Protection in Rats.
非偶然急性疼痛应激驱动大鼠镇痛保护。
- 批准号:
575854-2022 - 财政年份:2022
- 资助金额:
$ 61.73万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Master's
Prefrontal Cortex Hemodynamic Responses to Mindfulness Meditation and Acute Pain
前额皮质血流动力学对正念冥想和急性疼痛的反应
- 批准号:
467076 - 财政年份:2021
- 资助金额:
$ 61.73万 - 项目类别:
Studentship Programs
A Multimodal Approach for Monitoring Prolonged Acute Pain in Neonates
监测新生儿长期急性疼痛的多模式方法
- 批准号:
9979265 - 财政年份:2020
- 资助金额:
$ 61.73万 - 项目类别:
A Multimodal Approach for Monitoring Prolonged Acute Pain in Neonates
监测新生儿长期急性疼痛的多模式方法
- 批准号:
10218273 - 财政年份:2020
- 资助金额:
$ 61.73万 - 项目类别: